Pharmaceutical

The FDA issued a warning letter to Amneal Pharmaceuticals criticizing the drugmaker for failing to correct problems that led to a string of recalls of...

ImmunoPrecise Antibodies has cemented a recent shift in its focus by adopting a new name: MindWalk. The new brand, which also covers the company’s Bio...

Citing a “new evidenced based philosophy,” the FDA’s Center for Biologics Evaluation and Research (CBER) is preparing to take a hard line against the...

Department of Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. has selected seven new experts that he plans to nominate to the Advisory...

As the annual U.S. Conference on HIV/AIDS (USCHA) kicks off in Washington, D.C., this week with a focus on aging with HIV, Gilead Sciences is rolling...

The Food and Drug Administration today announced a plan to publicly release complete response letters at the same time they are issued to sponsoring c...

During a tense and at times incendiary senate hearing Thursday, Robert F. Kennedy Jr. blamed the pharmaceutical industry and fell back on vaccine misi...

Dive Brief: Enveda Biosciences said Thursday it raised $150 million in Series D financing, doubling the cash it’s pulled in from venture capitalists t...

Dive Brief: Sanofi shares dropped after the French drugmaker reported results from a highly anticipated study of a new kind of medicine for eczema tha...

Dive Brief: The Food and Drug Administration plans to work more closely and flexibly with developers of drugs for certain ultra-rare conditions, outli...